lymphoma, hodgkin

Showing 1 - 12 of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Lymphoma, B-Cell, Lymphoma, Hodgkin, Exercise Trial in Copenhagen (Resistance Exercise Training)

Recruiting
  • Lymphoma, B-Cell
  • +8 more
  • Resistance Exercise Training
  • Copenhagen, Denmark
    Rigshospitalet
Oct 25, 2022

Leukemia, Myeloid, Acute, Leukemia, B-cell, Leukemia, T Cell Trial in Monza (Sport Therapy)

Recruiting
  • Leukemia, Myeloid, Acute
  • +7 more
  • Sport Therapy
  • Monza, MB, Italy
    Maria Letizia Verga Center, Pediatric Clinic, University of Mila
Oct 24, 2022

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln

Completed
  • Lymphoma, Hodgkin
  • +2 more
  • Myo-Inositol and D-Chiro-Inositol (MIC)
  • Bari, Italy
    IRCCS - Istituto Oncologico"Giovanni PaoloII"
Jun 2, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin Trial (intervention)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Lymphoma, Hodgkin
  • intervention
  • (no location specified)
Feb 9, 2022

Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Hodgkin Trial in France (MOOVCARE)

Terminated
  • Lymphoma, T-Cell
  • +2 more
  • MOOVCARE
  • Vannes, Bretagne, France
  • +14 more
Apr 2, 2021

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (OT-82 Dose Escalation, OT-82 Dose Expansion)

Recruiting
  • Lymphoma
  • +6 more
  • OT-82 Dose Escalation
  • OT-82 Dose Expansion
  • Birmingham, Alabama
  • +7 more
Oct 22, 2020

Lymphoma, Non-Hodgkin, Lymphoma, Hodgkin, Myeloma Trial in Monterrey (Plerixafor 0.12 mg/kg)

Unknown status
  • Lymphoma, Non-Hodgkin
  • +3 more
  • Plerixafor 0.12 mg/kg
  • Monterrey, Nuevo Leon, Mexico
    Servicio de Hematología Hospital Universitario "Dr. José Eleuter
Aug 9, 2017

Leukemia, Cancer, Lymphoma Trial in Houston (Ara C, Mesna, Cyclophosphamide)

Terminated
  • Leukemia
  • +4 more
  • Ara C
  • +3 more
  • Houston, Texas
    Texas Children's Hospital
Mar 24, 2016

MELT - MRI Evaluation of Lymphoma Treatment

Completed
  • Lymphoma, Hodgkin
    • London, United Kingdom
      University College London Hospital (UCLH)
    Dec 1, 2015